Latest Breaking News On - Adaptcycle trial - Page 1 : comparemela.com

Beyond genomic testing, endocrine therapy response should be used to determine whether patients with hormone receptor–positive, HER2-negative, N0-1 early breast cancer.

San-antonio
Texas
United-states
Germany
German
West-german
Oleg-gluz
German-study-group
Antonio-breast-cancer
West-german-study-group
Adaptcycle-trial-
Nct04055493